We are live on ! Find out more
CSPIA

Cary Street Partners Investment Advisory Portfolio holdings

AUM $494M
1-Year Est. Return 27.12%
This Fund
S&P 500
This Quarter Est. Return
+5.74%
1 Year Est. Return
+27.12%
3 Year Est. Return
+84.09%
5 Year Est. Return
+94.67%
10 Year Est. Return
AUM
$1.56B
AUM Growth
+$164M
Cap. Flow
+$94.6M
Cap. Flow %
6.08%
Top 10 Hldgs %
18.51%
Holding
1,811
New
134
Increased
495
Reduced
356
Closed
61
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAW icon
1201
Vanguard Materials ETF
VAW
$3.05B
$11.5K ﹤0.01%
63
URTH icon
1202
iShares MSCI World ETF
URTH
$8.4B
$11.5K ﹤0.01%
92
SRPT icon
1203
Sarepta Therapeutics
SRPT
$1.95B
$11.5K ﹤0.01%
100
BIZD icon
1204
VanEck BDC Income ETF
BIZD
$1.71B
$11.4K ﹤0.01%
743
NBIX icon
1205
Neurocrine Biosciences
NBIX
$15.3B
$11.4K ﹤0.01%
121
+12
+11% +$1.17K
UUP icon
1206
Invesco DB US Dollar Index Bullish Fund
UUP
$414M
$11.4K ﹤0.01%
400
XP icon
1207
XP
XP
$8.18B
$11.3K ﹤0.01%
+482
New +$8.18K
IOVA icon
1208
Iovance Biotherapeutics
IOVA
$2.95B
$11.3K ﹤0.01%
1,600
CALX icon
1209
Calix
CALX
$2.51B
$11.2K ﹤0.01%
225
SANM icon
1210
Sanmina
SANM
$11.1B
$11.2K ﹤0.01%
186
HSBC icon
1211
HSBC
HSBC
$358B
$11.2K ﹤0.01%
282
HOG icon
1212
Harley-Davidson
HOG
$2.9B
$11.1K ﹤0.01%
316
WIP icon
1213
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$474M
$11.1K ﹤0.01%
265
+200
+308% +$8.39K
FM
1214
DELISTED
iShares Frontier and Select EM ETF
FM
$10.9K ﹤0.01%
423
+7
+2% +$178
AI icon
1215
C3.ai
AI
$1.58B
$10.9K ﹤0.01%
300
IFF icon
1216
International Flavors & Fragrances
IFF
$21.4B
$10.9K ﹤0.01%
137
HBI
1217
DELISTED
Hanesbrands
HBI
$10.9K ﹤0.01%
2,400
+1,210
+102% +$5.53K
CCD
1218
Calamos Dynamic Convertible & Income Fund
CCD
$755M
$10.9K ﹤0.01%
+500
New +$11.2K
AGGY icon
1219
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$926M
$10.9K ﹤0.01%
+252
New +$11K
CEF icon
1220
Sprott Physical Gold and Silver Trust
CEF
$8.17B
$10.8K ﹤0.01%
600
HELE icon
1221
Helen of Troy
HELE
$699M
$10.8K ﹤0.01%
100
TAK icon
1222
Takeda Pharmaceutical
TAK
$55.5B
$10.8K ﹤0.01%
687
KNX icon
1223
Knight Transportation
KNX
$11.9B
$10.8K ﹤0.01%
194
IIIN icon
1224
Insteel Industries
IIIN
$634M
$10.8K ﹤0.01%
346
MGA icon
1225
Magna International
MGA
$18.7B
$10.7K ﹤0.01%
190

Similar funds

Cary Street Partners Investment Advisory's Q2 2023 Portfolio in Review

As of Q2 2023, Cary Street Partners Investment Advisory held 1,811 positions worth $1.56B, up 12% from $1.39B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cary Street Partners Investment Advisory deployed $94.6M of net new capital in Q2 2023, opening 134 new positions and adding to 495 existing holdings. Its largest new stake was Franklin International Core Dividend Tilt Index ETF: 202,350 shares worth $5.91M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Ultra Short Duration Bond Active ETF, an estimated $7.96M trimmed.

  • Cary Street Partners Investment Advisory's largest Q2 2023 buy was Franklin International Core Dividend Tilt Index ETF: 202,350 shares worth $5.91M.
  • Cary Street Partners Investment Advisory added most to Vanguard Intermediate-Term Bond ETF in Q2 2023, an estimated $15.7M increase.
  • Cary Street Partners Investment Advisory's biggest Q2 2023 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $7.96M.
  • Cary Street Partners Investment Advisory fully exited SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML) in Q2 2023, selling an estimated $12M.
  • Cary Street Partners Investment Advisory's ten largest holdings make up 19% of its $1.56B portfolio in Q2 2023.
  • Cary Street Partners Investment Advisory opened 134 new positions and closed 61 in Q2 2023.
  • Cary Street Partners Investment Advisory's portfolio value rose 12% quarter-over-quarter to $1.56B.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2023, filed 10 Aug 2023.